Carcinoembryonic Antigen Market Growth, Future Prospects and Marketing Strategies, Industry Forecast To 2025
Carcinoembryonic Antigen Market Growth, Future Prospects and Marketing Strategies, Industry Forecast To 2025
(firmenpresse) - The latest market report published by Credence Research, Inc. 2023.
Market Insights
According to Quest Diagnostics, CEA is an oncofetal glycoprotein present in the gastrointestinal tract and body fluids of the embryo and fetus. This antigen is also present in certain adult gastrointestinal cells, including the mucosal cells of the colorectum, and small amounts are present in blood. Market experts suggest that key growth drivers assisting the growth of CEA market comprises high prevalence of cancer, mounting global geriatric population base, high demand for minimally invasive diagnostic procedures in cancer and increasing application of CEA for diagnosis at several stages of cancer. In addition, a few factors that assist the overall market growth are growing healthcare expenditure which is boosting the need for efficient diagnostic procedure for cancer and influencing the usage of combination biomarkers.
Browse the full report Carcinoembryonic Antigen (CEA) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016
The global carcinoembryonic antigen (CEA) market is segmented on the basis of application type into ovarian cancer, colorectal cancer, pancreatic cancer, lung cancer, breast cancer, thyroid cancer and other cancers. In base year 2015, colorectal cancer dominated the overall market in terms of revenue. The key factors responsible for growth of CEA market are increase in number of population consuming alcohol, sedentary lifestyle, and high intake of saturated fats in all age groups. Moreover, rising preference for CEA test in cancer diagnosis and management is expected to assist its market growth in the near future.
In base year 2015, North America was observed as the largest CEA market due to high public awareness related to early cancer diagnosis, rising preference for minimally invasive cancer diagnosis tests and sophisticated health care facilities for cancer management. Incessant technological developments followed by new discoveries of specific antigens and biomarkers are anticipated to boost the growth of CEA market testing. The key factors assisting the growth of CEA market comprises aging population, highly accessible technologically advanced healthcare facilities, successful governmental and non-governmental initiatives, and demand for precise diagnostic procedures.
Market Competition Assessment:
The carcinoembryonic antigen (CEA) market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Quest Diagnostics, F. Hoffman LA Roche, Abbott Laboratories, GenWay Biotech Inc., Correlogic Systems, Inc., and Others.
Browse the full report Carcinoembryonic Antigen (CEA) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016
Key Market Movements:
s
Latest Report
https://www.credenceresearch.com/report/dental-implants-market
https://www.credenceresearch.com/report/kerosene-jet-a-1-market
https://www.credenceresearch.com/report/x-ray-equipment-market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we
Media Contact
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Email: sales(at)credenceresearch.com
Web: http://www.credenceresearch.com/
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
8003618290
Datum: 27.12.2017 - 05:00 Uhr
Sprache: Deutsch
News-ID 1530873
Anzahl Zeichen: 5127
contact information:
Contact person: jayvir singh
Town:
San Jose
Phone: 18003618290
Kategorie:
Research & Development
Typ of Press Release: Erfolgsprojekt
type of sending: Veröffentlichung
Date of sending: 27.12.2017
Anmerkungen:
Diese Pressemitteilung wurde bisher 1119 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Carcinoembryonic Antigen Market Growth, Future Prospects and Marketing Strategies, Industry Forecast To 2025
"
steht unter der journalistisch-redaktionellen Verantwortung von
Credence Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
